Attention deficit hyperactivity disorder and specific learning disability co-occurring in a case with Silver-Russell syndrome

Abstract

This case presentation discusses the management of comorbid attention deficit hyperactivity disorder (ADHD) and specific learning disability (SLD) in a female adolescent diagnosed with Silver-Russell syndrome (SRS). A 13-year-old female patient presented to the child psychiatry outpatient clinic eight months ago with complaints of reading and writing difficulties and forgetfulness. When she was four years old, she was diagnosed with SRS. Somatotropin therapy was initiated for the patient. Based on psychiatric examination, family interviews, psychometric assessments, and information obtained from school, the patient was diagnosed with ADHD and SLD. The patient was started on methylphenidate treatment, gradually titrated to a dose of 27 mg/day. She was also referred for special education for the SLD diagnosis. In the literature, it has been reported that in most children with SRS, intelligence is within the normal range, and they often receive diagnoses of ADHD and/or SLD. Studies have shown that although, executive function disorders are not significantly associated with SRS in comparison to control groups, there is an increased risk. Children and adolescents with this rare congenital disorder are at risk for psychiatric disorders, and periodic evaluation by a child psychiatrist is recommended.

Keywords

• Silver-Russell syndrome
• Attention deficit hyperactivity disability
• Specific learning disorder
• Child
• Neurodevelopmental disorders

References

1. Wakeling EL, Brioude F, Lokulo-Sodipe O, et al. Diagnosis and management of Silver-Russell syndrome: first international consensus statement. Nat Rev Endocrinol 2017;13:105-24. doi:10.1038/nrendo.2016.138
2. Perkins RM, Hoang-Xuan MT. The Russell-Silver syndrome: a case report and brief review of the literature. Pediatr Dermatol 2002;19:546-9. doi:10.1046/j.1525-1470.2002.00230.x
3. Saal HM, Harbison MD, Netchine I. Silver-Russell syndrome: In: Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Bean LJH, Gripp KW, Amemiya A, eds. GeneReviews(R). Seattle (WA): University of Washington, 1993.
4. Ballard LM, Fenwick A, Jenkinson E, Temple IK. Falling short? The psychosocial impact of living with Russell-Silver syndrome. JAN 2016;5:340-2. doi:10.12968/joan.2016.5.7.340
5. American Psychiatric Association. DSM-5 Task Force. Diagnostic and statistical manual of mental disorders : DSM-5. 5th ed. Washington, D.C., American Psychiatric Association, 2013.
6. Özbek MM, Aksu H. Dikkat eksikliği hiperaktivite bozukluğu nedir? Ne değildir?: In: Toros F, Aksu GG, eds. Dikkat Eksikliği ve Hiperaktivite Bozukluğu ile İlgili Her Şey. Ankara: Akademisyen Kitabevi, 2019:21-30.
7. Shapiro BK, Gallico RP. Learning disabilities. Pediatr Clin North Am 1993;40:491-505. doi:10.1016/s0031- 3955(16)38546-7
8. Mukherjee S, Shah HR, Ramanathan S, Dewan M. Knowledge and attitudes about attention-deficit/hyperactivity disorder and specific learning disorder in an urban indian population. J Nerv Ment Dis 2016;204:458-63. doi:10.1097/ NMD.000.000.0000000524

9. Shayle A. Assessing the cognitive, behavioural and psychosocial profile of children with Russell Silver Syndrome. School of Psychology. Birmingham, University of Birmingham College of Life and Environmental Science, 2009:279.
10. Turgay A. Disruptive behavior disorders child and adolescent screening and rating scale for children, adolescents, parents, and teachers. West Blomfield (Michigan): Integrative Therapy Institute Publication, 1994.
11. Savaşır I, Şahin N. Wechsler Çocuklar için Zeka Ölçeği (WISC-R). Ankara: Millli Eğitim Basımevi, 1998.
12. Karakaş S, Erden G, Bakar EE, Doğutepe E: Özgül Öğrenme Bozukluğu Genişletilmiş Nöropsikometri Bataryası. Konya: Eğitim Yayınevi, 2017.
13. Eggermann T. Russell-Silver syndrome. Am J Med Genet Part C 2010;154C:355-364. doi:10.1002/ajmg.c.30274
14. Rakover Y, Dietsch S, Ambler GR, Chock C, Thomsett M, Cowell CT. Growth hormone therapy in Silver Russell syndrome: 5 years experience of the Australian and New Zealand Growth database (OZGROW). EJPE 1996;155: 851- 7. doi:10.1007/BF02282833
15. Maruff P, Falleti M. Cognitive function in growth hormone deficiency and growth hormone replacement. Horm Res 2005;64 Suppl 3:100-8. doi:10.1159/000089325
16. Subcommittee on Attention-Deficit/Hyperactivity Disorder; Steering Committee on Quality Improvement and Management; Wolraich M, Brown L, Brown RT, et al. ADHD: clinical practice guideline for the diagnosis, evaluation, and treatment of attention-deficit/hyperactivity disorder in children and adolescents. Pediatrics 2011;128:1007-22. doi:10.1542/peds.2011-2654
17. Storebo OJ, Pedersen N, Ramstad E, et al. Methylphenidate for attention deficit hyperactivity disorder (ADHD) in children and adolescents – assessment of adverse events in nonrandomised studies. Cochrane Database Syst Rev 2018;5: CD012069. doi:10.1002/14651858.CD012069.pub2
18. Semrud-Clikeman M, Biederman J, Sprich-Buckminster S, Lehman BK, Faraone SV, Norman D. Comorbidity between ADDH and learning disability: a review and report in a clinically referred sample. J Am Acad Child Adolesc Psychiatr 1992;31:439-48. doi:10.1097/00004.583.199205000-00009
19. DuPaul GJ, Volpe RJ. ADHD and learning disabilities: Research findings and clinical implications. Curr Atten Disord Rep 2009;1:152-5. doi:10.1007/s12618.009.0021-4
20. Araz-Altay M, Görker I, Demirci-Şipka B, Bozatlı L, Ataş T. Attention deficit hyperactivity disorder and psychiatric comorbidities. EJFM 2020; 9:27-34. doi:10.33880/ ejfm.202.009.0104
21. Pasini A, Paloscia C, Alessandrelli R, Porfirio MC, Curatolo P. Attention and executive functions profile in drug naive ADHD subtypes. Brain Dev 2007;29:400-8. doi:10.1016/j. braindev.2006.11.010
22. Burgevin M, Lacroix A, Ollivier F, et al. Executive functioning in adolescents and adults with Silver-Russell syndrome. PloS ONE 2023;18:e0279745. doi:10.1371/journal.pone.0279745
23. Burgevin M, Lacroix A, Bourdet K, et al. Quality of life and mental health of adolescents and adults with Silver-Russell syndrome. Eur J Med Genet 2022;65:104482. doi:10.1016/j. ejmg.2022.104482
24. Puri M, Badillo M, Islam F, Hall E. Major depressive disorder: A Case of an adolescent female with Russell-Silver syndrome. JCALB 2014;2:135. doi:10.4172/2375-4494.100.0135
25. Margari L, Buttiglione M, Craig F, et al. Neuropsychopathological comorbidities in learning disorders. BMC Neurol 2013;13:198. doi:10.1186/1471-2377-13-198